<code id='1DE6F7316D'></code><style id='1DE6F7316D'></style>
    • <acronym id='1DE6F7316D'></acronym>
      <center id='1DE6F7316D'><center id='1DE6F7316D'><tfoot id='1DE6F7316D'></tfoot></center><abbr id='1DE6F7316D'><dir id='1DE6F7316D'><tfoot id='1DE6F7316D'></tfoot><noframes id='1DE6F7316D'>

    • <optgroup id='1DE6F7316D'><strike id='1DE6F7316D'><sup id='1DE6F7316D'></sup></strike><code id='1DE6F7316D'></code></optgroup>
        1. <b id='1DE6F7316D'><label id='1DE6F7316D'><select id='1DE6F7316D'><dt id='1DE6F7316D'><span id='1DE6F7316D'></span></dt></select></label></b><u id='1DE6F7316D'></u>
          <i id='1DE6F7316D'><strike id='1DE6F7316D'><tt id='1DE6F7316D'><pre id='1DE6F7316D'></pre></tt></strike></i>

          leisure time

          leisure time

          author:entertainment    Page View:6265
          After a drawn-out lobbying fight, ARPA-H chose its headquarters: a hub and spokes model, with three central locations in Boston, Texas, and D.C. David L. Ryan/Boston Globe

          WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed — before, in fact, anyone truly knew what ARPA-H was.

          But the lobbying campaign from universities, business leaders, members of Congress, and big-city mayors is finally over.

          advertisement

          The end came not with a dramatic reveal or a formal ribbon-cutting, but with a largely bureaucratic and anticlimactic announcement that the Biden administration plans to share the wealth. ARPA-H will be housed in a hub-and-spoke model across three major metro areas: The D.C. suburbs; Cambridge, Mass.; and Dallas. Additional “spokes,” the agency announced Tuesday, will be spread across the country at 10 sites spanning from Florida to Alaska.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Readout Newsletter: New research from Sanofi, Regeneron, etc.
          Readout Newsletter: New research from Sanofi, Regeneron, etc.

          HyacinthEmpinado/STATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiote

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Publishing genetic code of viruses could cause disaster

          HealthworkersatalabinHongKongtestingforcoronavirusinMarch2022.KinCheung/APThewhollysyntheticmRNAvacc